March 1, 2017 / 9:26 PM / 5 months ago

BRIEF-Amgen inc says to present new kyprolis and xgeva data

1 Min Read

March 2 (Reuters) - Amgen Inc

* Amgen inc says to present new Kyprolis and Xgeva data

* Amgen -detailed results from phase 3 head-to-head endeavor trial show kyprolis significantly improved overall survival compared to velcade Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below